NUVB

Nuvation Bio Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 1/10
  • Value↓ 0/10
Nuvation Bio sales and earnings growth
NUVB Growth
Low
  • Revenue Y/Y↑ 698.96%
  • EPS Y/Y↑ 71.56%
  • FCF Y/Y↓ -33.09%
Nuvation Bio gross and profit margin trends
NUVB Profitability
Neutral
  • Gross margin ↑ 85.20%
  • EPS margin↓ -325.30%
  • ROIC 5Y↓ -52.18%
Nuvation Bio net debt vs free cash flow
NUVB Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 0.3
  • Interest coverage↓ -14.0

Nuvation Bio stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗